Literature DB >> 20821260

IGF-1 reduces BACE-1 expression in PC12 cells via activation of PI3-K/Akt and MAPK/ERK1/2 signaling pathways.

Hua Zhang1, Ying Gao, Zhengwei Dai, Tao Meng, Shengfen Tu, Yong Yan.   

Abstract

Insulin-like growth factor 1 (IGF-1) stimulates α-secretase processing of amyloid precursor protein (APP) and decreases Aβ production. Little is known about the relationship between IGF-1 and β-site amyloid precursor protein cleaving enzyme 1 (BACE-1), the protease essential for the production of β-amyloid peptides (Aβ). Here, we investigated the effect of IGF-1 on BACE-1 in PC12 cells. Quantitative polymerase chain reaction analysis and western blot showed that treatment of cells with IGF-1 significantly decreased the levels of BACE-1 mRNA and protein. Furthermore, IGF-1 increased the phosphorylation of Akt and ERK1/2. The presence of the phosphatidylinositol 3-kinase (PI3-K) inhibitor LY294002 and the mitogen-activated protein kinase kinases (MEK) inhibitor PD98059 blocked the effect of IGF-1 on BACE-1. Our data indicated that IGF-1-induced reduction of BACE-1 might involve the PI3-K/Akt and MAPK/ERK1/2 signaling pathways.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20821260     DOI: 10.1007/s11064-010-0260-x

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  35 in total

Review 1.  The role of insulin and insulin-like growth factor I in the molecular and cellular mechanisms underlying the pathology of Alzheimer's disease.

Authors:  Eva Carro; Ignacio Torres-Aleman
Journal:  Eur J Pharmacol       Date:  2004-04-19       Impact factor: 4.432

Review 2.  Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective.

Authors:  Rudolph E Tanzi; Lars Bertram
Journal:  Cell       Date:  2005-02-25       Impact factor: 41.582

3.  Relationship between serum insulin-like growth factor-1 levels and Alzheimer's disease and vascular dementia.

Authors:  Takuya Watanabe; Akira Miyazaki; Takashi Katagiri; Hideki Yamamoto; Tsunenori Idei; Takashi Iguchi
Journal:  J Am Geriatr Soc       Date:  2005-10       Impact factor: 5.562

4.  Beta-site APP cleaving enzyme up-regulation induced by 4-hydroxynonenal is mediated by stress-activated protein kinases pathways.

Authors:  Elena Tamagno; Maurizio Parola; Paola Bardini; Alessandra Piccini; Roberta Borghi; Michela Guglielmotto; Gianni Santoro; Annalisa Davit; Oliviero Danni; M A Smith; G Perry; Massimo Tabaton
Journal:  J Neurochem       Date:  2005-02       Impact factor: 5.372

5.  BACE1, a major determinant of selective vulnerability of the brain to amyloid-beta amyloidogenesis, is essential for cognitive, emotional, and synaptic functions.

Authors:  Fiona M Laird; Huaibin Cai; Alena V Savonenko; Mohamed H Farah; Kaiwen He; Tatyana Melnikova; Hongjin Wen; Hsueh-Cheng Chiang; Guilian Xu; Vassilis E Koliatsos; David R Borchelt; Donald L Price; Hey-Kyoung Lee; Philip C Wong
Journal:  J Neurosci       Date:  2005-12-14       Impact factor: 6.167

Review 6.  Growth hormone and insulin-like growth factor-1 (IGF-1) and their influence on cognitive aging.

Authors:  William E Sonntag; Melinda Ramsey; Christy S Carter
Journal:  Ageing Res Rev       Date:  2005-05       Impact factor: 10.895

7.  Puerarin protects PC12 cells against beta-amyloid-induced cell injury.

Authors:  Hai-Ying Zhang; Yi-Heng Liu; Hong-Quan Wang; Jie-Hua Xu; Hai-Tao Hu
Journal:  Cell Biol Int       Date:  2008-07-16       Impact factor: 3.612

8.  A general procedure for the purification of human beta-secretase expressed in Escherichia coli.

Authors:  Vinod Sardana; Bei Xu; Joan Zugay-Murphy; Zhongguo Chen; Mohinder Sardana; Paul L Darke; Sanjeev Munshi; Lawrence C Kuo
Journal:  Protein Expr Purif       Date:  2004-04       Impact factor: 1.650

9.  GSK-3alpha regulates production of Alzheimer's disease amyloid-beta peptides.

Authors:  Christopher J Phiel; Christina A Wilson; Virginia M-Y Lee; Peter S Klein
Journal:  Nature       Date:  2003-05-22       Impact factor: 49.962

10.  Secretion of beta-amyloid precursor protein cleaved at the amino terminus of the beta-amyloid peptide.

Authors:  P Seubert; T Oltersdorf; M G Lee; R Barbour; C Blomquist; D L Davis; K Bryant; L C Fritz; D Galasko; L J Thal
Journal:  Nature       Date:  1993-01-21       Impact factor: 49.962

View more
  16 in total

1.  The phosphatidyl inositol 3 kinase-glycogen synthase kinase 3β pathway mediates bilobalide-induced reduction in amyloid β-peptide.

Authors:  Chun Shi; Dong-dan Zheng; Feng-ming Wu; Jun Liu; Jie Xu
Journal:  Neurochem Res       Date:  2011-09-28       Impact factor: 3.996

2.  MicroRNA-98 induces an Alzheimer's disease-like disturbance by targeting insulin-like growth factor 1.

Authors:  Yi-Kui Hu; Xun Wang; Lian Li; Yan-Hua Du; Heng-Tai Ye; Cheng-Yan Li
Journal:  Neurosci Bull       Date:  2013-06-05       Impact factor: 5.203

3.  Cross-species genetic screens to identify kinase targets for APP reduction in Alzheimer's disease.

Authors:  Claudia H Huichalaf; Ismael Al-Ramahi; Kyung-Won Park; Stacy D Grunke; Nan Lu; Maria de Haro; Karla El-Zein; Tatiana Gallego-Flores; Alma M Perez; Sung Yun Jung; Juan Botas; Huda Y Zoghbi; Joanna L Jankowsky
Journal:  Hum Mol Genet       Date:  2019-06-15       Impact factor: 6.150

Review 4.  The Role of ERK1/2 Pathway in the Pathophysiology of Alzheimer's Disease: An Overview and Update on New Developments.

Authors:  Mohammad Rafi Khezri; Keyvan Yousefi; Ayda Esmaeili; Morteza Ghasemnejad-Berenji
Journal:  Cell Mol Neurobiol       Date:  2022-01-17       Impact factor: 5.046

Review 5.  All roads lead to Rome - a review of the potential mechanisms by which exerkines exhibit neuroprotective effects in Alzheimer's disease.

Authors:  Yi-Yao Liang; Li-Dan Zhang; Xi Luo; Li-Li Wu; Zhao-Wei Chen; Guang-Hao Wei; Kai-Qing Zhang; Ze-An Du; Ren-Zhi Li; Kwok-Fai So; Ang Li
Journal:  Neural Regen Res       Date:  2022-06       Impact factor: 5.135

6.  SRPK1 gene silencing promotes vascular smooth muscle cell proliferation and vascular remodeling via inhibition of the PI3K/Akt signaling pathway in a rat model of intracranial aneurysms.

Authors:  Xin-Guo Li; Yi-Bao Wang
Journal:  CNS Neurosci Ther       Date:  2018-08-12       Impact factor: 5.243

7.  Effects of an amyloid-beta 1-42 oligomers antibody screened from a phage display library in APP/PS1 transgenic mice.

Authors:  Jianping Wang; Nan Li; Jun Ma; Zhiqiang Gu; Lie Yu; Xiaojie Fu; Xi Liu; Jian Wang
Journal:  Brain Res       Date:  2016-01-25       Impact factor: 3.252

8.  Blocking c-Met signaling enhances bone morphogenetic protein-2-induced osteoblast differentiation.

Authors:  Seiji Shibasaki; Sachie Kitano; Miki Karasaki; Sachi Tsunemi; Hajime Sano; Tsuyoshi Iwasaki
Journal:  FEBS Open Bio       Date:  2015-04-20       Impact factor: 2.693

9.  Human neural stem cells alleviate Alzheimer-like pathology in a mouse model.

Authors:  Il-Shin Lee; Kwangsoo Jung; Il-Sun Kim; Haejin Lee; Miri Kim; Seokhwan Yun; Kyujin Hwang; Jeong Eun Shin; Kook In Park
Journal:  Mol Neurodegener       Date:  2015-08-21       Impact factor: 14.195

10.  IGF-1 promotes Brn-4 expression and neuronal differentiation of neural stem cells via the PI3K/Akt pathway.

Authors:  Xinhua Zhang; Lei Zhang; Xiang Cheng; Yuxiu Guo; Xiaohui Sun; Geng Chen; Haoming Li; Pengcheng Li; Xiaohui Lu; Meiling Tian; Jianbing Qin; Hui Zhou; Guohua Jin
Journal:  PLoS One       Date:  2014-12-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.